Clinical trials sponsored by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase breakdown

Conditions studied

Recruiting trials led by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

• Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)
  NCT05893381 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Vaccination with Autologous Dendritic Cells Loaded with Autologous Tumour Homogenate After Curative Resection for Stage IV Colorectal Cancer.
  NCT02919644 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• Whole Body MRI in Oncology
  NCT06895291 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Common questions

How many trials is Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS recruiting for?

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.